RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older

被引：8

作者：

Surie, Diya ^{[1
]}

Self, Wesley H. ^{[2
]}

Zhu, Yuwei ^{[3
]}

Yuengling, Katharine A. ^{[1
]}

Johnson, Cassandra A. ^{[3
]}

Grijalva, Carlos G. ^{[4
]}

Dawood, Fatimah S. ^{[1
]}

机构：

[1] CDCP, Coronavirus & Other Resp Viruses Div, 1600 Clifton Rd,MS H18-6, Atlanta, GA 30329 USA

[2] Vanderbilt Univ, Vanderbilt Inst Clin & Translat Res, Med Ctr, Nashville, TN USA

[3] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA

[4] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 332卷 / 13期

关键词：

RESPIRATORY SYNCYTIAL VIRUS; STATES;

D O I：

10.1001/jama.2024.15775

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This study evaluates the effectiveness of the respiratory syncytial virus vaccine against hospitalization for acute respiratory illness among US adults aged 60 years and older.

引用

页码：1105 / 1107

页数：3

共 50 条

[31] COST-EFFECTIVENESS OF NIRSEVIMAB AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) AMONG US INFANTS EXPERIENCING THEIR FIRST RSV SEASON
Beuvelet, M.
Chung-Delgado, K.
Kieffer, A.
VALUE IN HEALTH, 2021, 24 : S110 - S110
[32] Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States
La, Elizabeth M.
Graham, Jonathan
Singer, David
Molnar, Daniel
Poston, Sara
Curran, Desmond
Pickett, Jessica
Verelst, Frederik
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
[33] Cost-effectiveness of 15-valent or 20-valent pneumococcal conjugate vaccine for US adults aged 65 years and older and adults 19 years and older with underlying conditions
Rosenthal, Melissa
Stoecker, Charles
Leidner, Andrew J.
Cho, Bo-Hyun
Pilishvili, Tamara
Kobayashi, Miwako
VACCINE, 2025, 44
[34] ESTIMATING THE EFFECTS OF A POTENTIAL VACCINE FOR CYTOMEGALOVIRUS ON DISABILITIES AMONG OLDER ADULTS IN THE US
He, Yuelin
Faul, Jessica
Duchowny, Kate
Li, Chihua
Stebbins, Rebecca
Noppert, Grace
INNOVATION IN AGING, 2023, 7 : 303 - 303
[35] Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season
Mira-Iglesias, Ainara
Lopez-Labrador, Fxavier
Baselga-Moreno, Victor
Tortajada-Girbes, Miguel
Mollar-Maseres, Juan
Carballido-Fernandez, Mario
Schwarz-Chavarri, German
Puig-Barbera, Joan
Diez-Domingo, Javier
EUROSURVEILLANCE, 2019, 24 (31) : 11 - 22
[36] Adjuvanted Vaccine to Prevent Respiratory Syncytial Virus in Adults Ages 60 Years and Older
Gennattasio, Annmarie
NURSING FOR WOMENS HEALTH, 2024, 28 (03) : 242 - 246
[37] Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older
De Villiers, Pierre J. T.
Steele, A. Duncan
Hiemstra, Louis A.
Rappaport, Ruth
Dunning, Andrew J.
Gruber, William C.
Forrest, Bruce D.
VACCINE, 2009, 28 (01) : 228 - 234
[38] Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults
Goswami, Jaya
Baqui, Abdullah H.
Doreski, Pablo A.
Marc, Gonzalo Perez
Jimenez, Gilberto
Ahmed, Salahuddin
Zaman, Khalequz
Duncan, Christopher J. A.
Ujiie, Mugen
Ramet, Mika
Perez-Breva, Lina
Lan, Lan
Du, Jiejun
Kapoor, Archana
Mehta, Shraddah
Tomassini, Joanne E.
Huang, Wenmei
Zhou, Honghong
Stoszek, Sonia K.
Priddy, Frances
Lin, Nina
Le Cam, Nancy
Shaw, Christine A.
Slobod, Karen
Wilson, Eleanor
Miller, Jacqueline M.
Das, Rituparna
JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (05): : e996 - e1006
[39] DEPRESSION AND HANDGRIP STRENGTH AMONG US ADULTS AGED 60 YEARS AND OLDER FROM NHANES 2011-2014
Brooks, J. M.
Titus, A. J.
Bruce, M. L.
Orzechowski, N. M.
Mackenzie, T. A.
Bartels, S. J.
Batsis, J. A.
JOURNAL OF NUTRITION HEALTH & AGING, 2018, 22 (08): : 938 - 943
[40] Association of obesity indicators with cognitive function among US adults aged 60 years and older: Results from NHANES
Chen, Leian
Hou, Ying
Sun, Yu
Peng, Dantao
BRAIN AND BEHAVIOR, 2024, 14 (09):

← 1 2 3 4 5 →